Mfi Biotechnology Co.,LTD

Healthier Animals,

Healthier Humans

Healthier Animals,

Healthier Humans

Healthier Animals,

Healthier Humans

Healthier Animals,

Healthier Humans

Company Profile

We are a professional animal health enterprise focused on the full value chain of animal vaccines, integrating R&D, production, sales, technical services, and talent development. Driven by innovation and practical application, we provide reliable vaccine products and comprehensive technical solutions for the global animal health industry.

Guided by the vision of “Healthier Animals, Healthier Humans”, we adhere to the principle that prevention is more important than treatment. Supported by an experienced technical team, our solutions cover poultry, swine, cattle, sheep, pets, and specialty animals, including disease prevention, diagnosis, and full-process technical support.

With stable partnerships across Asia, Africa, and other regions, and continuous expansion into Eurasia and Southeast Asia, we are committed to delivering high-quality animal health solutions worldwide with a professional, responsible, and international mindset.

News & Insights

The 140th Canton Fair 2026 | Connecting Global Markets, Creating New Opportunities

Guangzhou, China – October 15, 2026 The 140th China Import and Export Fair (Canton Fair) officially opened in Guangzhou on October 15, 2026, bringing together international buyers, manufacturers, and business professionals from around the world to explore new opportunities for global trade and cooperation. As a professional Chinese supplier and exporter of veterinary vaccines, we are committed to providing high-quality, safe, and reliable animal health solutions to customers worldwide. Our product portfolio covers a wide range of veterinary vaccines, including poultry vaccines, cattle and sheep vaccines, swine vaccines, and pet vaccines. The Canton Fair serves as an important platform for showcasing the strength of Chinese manufacturing and promoting international business partnerships. It also highlights China's growing role in global trade and technological i...
Advances in Novel Avian Vaccine Research: Paving the Way for Safer Poultry Farmin

Avian infectious diseases have long been a major threat to the global poultry industry, causing substantial economic losses and posing potential risks to public health. The development of novel vaccines has emerged as a key solution to tackle these challenges. A comprehensive review by Song Yuefeng, titled "Advances in Novel Avian Vaccine Research", systematically explores the technical types, research progress, application challenges, and future prospects of novel avian vaccines. This article summarizes the core insights of the review, shedding light on how cutting-edge vaccine technologies are revolutionizing avian disease control. Major Types and Characteristics of Novel Avian Vaccines Novel avian vaccines encompass a diverse range of technologies, each with unique immune mechanisms, advantages, and limitations. Here’s a detailed breakdown: Inactivated Vacci...
Insights into the Genomic Differences and Pathogenic Characteristics of Porcine Circoviruses (PCV2-PCV4）

Porcine Circoviruses (PCVs) are a group of significant pathogens threatening the global swine industry, with four identified genotypes to date: PCV1 to PCV4. Among them, PCV1 is non-pathogenic to pigs, while PCV2, PCV3, and PCV4 have been confirmed to cause various diseases in swine. Since PCV2 was identified as the primary etiological agent of Postweaning Multisystemic Wasting Syndrome (PMWS) in 1998, extensive research has clarified its pathogenic mechanisms and prevention strategies. In recent years, with in-depth studies on the newly discovered PCV3 and PCV4, their pathogenic roles have become increasingly evident. This article provides a comprehensive overview of the differences in clinical signs, tissue pathological damage, antibody and cytokine levels, and immune response characteristics among PCV2, PCV3, and PCV4, aiming...
Understand Infectious Coryza in Chickens: Scientific Prevention and Control & MFIbio's Comprehensive Solution

Infectious coryza in chickens is a common bacterial disease threatening the poultry farming industry. It not only hinders chicken growth and causes a sharp drop in egg production but also easily leads to mixed infections, resulting in severe economic losses for the industry. MFIbio, deeply engaged in the field of animal disease prevention and control, relies on professional technology and a rich product portfolio to provide efficient prevention and control solutions for infectious coryza in chickens to farms worldwide, safeguarding breeding safety and benefits. 1. Infectious Coryza in Chickens: A Non-Negligible Threat to Breeding (1) Pathogen and Transmission Characteristics Infectious coryza is caused by Avibacterium paragallinarum (formerly known as Haemophilus paragallinarum, still widely used in clinical practice). This Gram-negative bacterium meas...

Qualifications & Certificates

We hold a full set of official authoritative certifications covering the whole process of animal vaccine R&D, production, quality control and export. All certificates are complete and valid, strictly complying with national and international industry standards and compliance requirements. Having obtained international qualification accreditation, our products meet the import access conditions of various countries, which lays a solid foundation for global export business and fully guarantees the quality, safety and reliability of the animal vaccines we provide to global customers.